Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W Seifarth
Gene Expression Signature of Primary Imatinib-Resistant Chronic Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Centrosome Aberrations in Chronic Myeloid Leukemia Correlate With Stage of Disease and Chromosomal Instability
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Decreased Expression of microRNA‑214 Contributes to Imatinib Mesylate Resistance of Chronic Myeloid Leukemia Patients by Upregulating ABCB1 Gene Expression
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
Characteristics of the TCR Vβ Repertoire in Imatinib-Resistant Chronic Myeloid Leukemia Patients With ABL Mutations
Science China Life Sciences
Genetics
Molecular Biology
Environmental Science
Biochemistry
Biological Sciences
Agricultural
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment Options for Patients With Chronic Myeloid Leukemia Who Are Resistant to or Unable to Tolerate Imatinib
Clinical Therapeutics
Pharmacology
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Imatinib and Plasmacytoid Dendritic Cell Function in Patients With Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
A Four-Gene LincRNA Expression Signature Predicts Risk in Multiple Cohorts of Acute Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Long-Term Safety and Efficacy of Dasatinib in the Treatment of Chronic-Phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib
Blood and Lymphatic Cancer: Targets and Therapy
